Viewing Study NCT02084849



Ignite Creation Date: 2024-05-06 @ 2:38 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02084849
Status: COMPLETED
Last Update Posted: 2015-06-24
First Post: 2014-03-10

Brief Title: ADPKD Cohort Study
Sponsor: Emory University
Organization: Emory University

Study Overview

Official Title: The Autosomal Dominant Polycystic Kidney Disease ADPKD Cohort Study
Status: COMPLETED
Status Verified Date: 2015-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to find out if radiology tests of the kidneys as opposed to glomerular filtration GFR tests GFR test - a lab test that measures kidney function follow progression of polycystic kidney disease PKD the best PKD patients at risk for progression to renal failure dialysis or transplantation have been identified and include those who have been diagnosed with high blood pressure early the presence of the PKD1 gene the inherited abnormality responsible for the majority of PKD men as opposed to women those with episodes of visible blood or increased protein in their urine and women who have experience more than three pregnancies Individuals who are diagnosed with PKD in the first year of life or in utero before birth are also at high risk for progression to renal failure

This study will also facilitate understanding of human diseases at the cellular and molecular level We will be identifying genetic factors that may influence the severity of polycystic kidney disease PKD You are being asked to provide a sample of blood for the purpose of DNA or other biochemical analyses
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
0247-1998 OTHER Other None